Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Extranodal NK-T-Cell × Ondansetron × 1 year × Clear all

Sponsor

Conditions

Vomiting 2 Vulvar Neoplasms 1 Vulvar Diseases 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Triple Negative Breast Neoplasms 1 Postoperative Nausea and Vomiting 1 Papillomavirus Infections 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Gynecologic Cancer 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Carcinoma, Hepatocellular 1 Carcinoma in Situ 1 Carcinoma 1 Burkitt Lymphoma 1 Breast Neoplasms 1

Interventions

pegaspargase 4 tislelizumab 2 fludarabine phosphate 2 Whole-Body Irradiation 2 Tacrolimus 2 Radiotherapy 2 Peripheral Blood Stem Cell Transplantation 2 Mycophenolic Acid 2 Etoposide 2 Cyclophosphamide 2 Busulfan 2 Azacitidine 2 sugemalimab 1 selinexor 1 relatlimab 1 pembrolizumab 1 gemcitabine-oxaliplatin regimen 1 fludarabine 1 Vorinostat 1 Valganciclovir 1 Transplantation 1 Thiotepa 1 Therapeutics 1 Sirolimus 1 Positron-Emission Tomography 1 Polymerase Chain Reaction 1 Oxaliplatin 1 Nivolumab 1 Methylprednisolone 1 Methotrexate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡